BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9838468)

  • 1. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case.
    Kita Y; Lake JR; Ferrell LD; Mori M; Roberts JP; Kakizoe S; Kiyosawa K; Tanaka E; Shiga J; Takikawa H; Inoue Y; Ohtake T; Ohtomo K; Yotsuyanagi H; Oka T; Harihara Y; Takayama T; Kubota K; Kawarasaki H; Hashikura Y; Kawasaki S; Ascher NL; Makuuchi M
    Transplant Proc; 1998 Nov; 30(7):3321-3. PubMed ID: 9838468
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary sclerosing cholangitis: providing a safe and effective treatment.
    Imam MH; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):255-7. PubMed ID: 22646247
    [No Abstract]   [Full Text] [Related]  

  • 3. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
    Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
    Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW
    Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
    Chapman RW
    Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis].
    Opitz OG; Thimme R; Kreisel W
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1827-30. PubMed ID: 12215927
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
    Stokkeland K; Höijer J; Bottai M; Söderberg-Löfdal K; Bergquist A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1860-1866.e1. PubMed ID: 30448601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
    Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
    Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and medical therapy of primary sclerosing cholangitis.
    van Milligen de Wit AW
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis and an abnormal cholangiogram.
    Nguyen DL; Lazaridis KN
    Cleve Clin J Med; 2011 May; 78(5):306-11. PubMed ID: 21536825
    [No Abstract]   [Full Text] [Related]  

  • 16. The resurgence of serum alkaline phosphatase as a surrogate biomarker for prognosis in primary sclerosing cholangitis.
    Talwalkar JA; Chapman RW
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):847-9. PubMed ID: 23591287
    [No Abstract]   [Full Text] [Related]  

  • 17. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Primary Sclerosing Cholangitis Including Transplantation.
    Wheless WH; Russo MW
    Clin Liver Dis; 2024 Feb; 28(1):171-182. PubMed ID: 37945158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.